Earnings Release • Nov 7, 2024
Earnings Release
Open in ViewerOpens in native device viewer

Christoph Jurecka, CFO
Munich Re generated a net result of $€ 930 \mathrm{~m}(1,169 \mathrm{~m})$ in Q3 2024. The year-on-year decline in the quarterly result is attributable to above-average major losses from natural catastrophes. In the first three quarters, the net result amounted to $€ 4,692 \mathrm{~m}(3,593 \mathrm{~m})$. Insurance revenue from insurance contracts issued increased to $€ 15,496 \mathrm{~m}(14,460 \mathrm{~m})$ from Q3 2023, and to $€ 45,510 \mathrm{~m}(42,908 \mathrm{~m})$ in Q1-3. The growth in both periods is due primarily to organic growth in all segments. For Q3, the total technical result declined to $€ 1,651 \mathrm{~m}(2,221 \mathrm{~m})$. The currency result totalled -€383m (309m), due primarily to foreign exchange losses in connection with the US dollar. The operating result fell to $€ 1,194 \mathrm{~m}(1,776 \mathrm{~m})$, and the effective tax rate was $18.2 \%(32.6 \%)$.
Equity amounted to €31,425m, higher than the figure at the start of the year (29,772m). The solvency ratio ${ }^{1}$ was 292\% (31 December 2023: 267\%), which is above the optimum range (175-220\%).
In Q3 2023, the annualised return on equity ${ }^{2}$ (RoE) came to 11.7\% (16.0\%), and in Q1-3 it reached 20.1\% (16.6\%).
In Q3, the reinsurance field of business contributed €766m (995m) to the net result; the contribution in Q1-3 totalled €3,993m (2,950m). Insurance revenue from insurance contracts issued increased in Q3 to €10,224m (9,456m). The total technical result declined to $€ 1,119 \mathrm{~m}(1,626 \mathrm{~m})$, and the operating result decreased to €956m (1,495m).
In Q3, life and health reinsurance generated a total technical result of €428m (440m). The contribution to the result from the release of the contractual service margin was in line with expectations. The net result in the segment moved up to €391m (351m). Insurance revenue from insurance contracts issued swelled to €2,936m (2,610m).
Property-casualty reinsurance generated a Q3 result of €375m (644m). Insurance revenue from insurance contracts issued rose to $€ 7,288 \mathrm{~m}(6,845 \mathrm{~m})$. The combined ratio amounted to $90.5 \%(82.0 \%)$ of net insurance revenue. In Q1-3 it was $82.0 \%$ (83.0\%). In Q3, the normalised combined ratio came to good $81.3 \%$.
Total major-loss expenditure increased significantly compared to the prior-year quarter, to $€ 1,609 \mathrm{~m}(770 \mathrm{~m})$. These figures include gains and losses from the run-off of major losses from previous years. The major-loss expenditure reached 23.1\% (11.7\%) of net insurance revenue, exceeding the expected figure of $14 \%$ in both Q3 and Q1-3 (15.9\%). Man-made major losses amounted to €225m (235m). Major losses from natural catastrophes surged to $€ 1,384 \mathrm{~m}$ (535m). The major-loss figures above take account of the effects from discounting and risk adjustment. Hurricane Helene, which caused severe damage in the southeastern United States and approximately €0.5bn in losses, was the largest single claims event. Three loss events in Canada together resulted in similar claims expenditure. In addition to numerous other natural catastrophes, significant damage occurred in central and eastern Europe due to Storm Boris and consequent flooding, as well as in the United States and the Caribbean due to Hurricane Beryl.
[^0]
[^0]: ${ }^{1}$ Does not include any transitional measures or deduction for dividends for financial year 2024 to be paid in 2025.
${ }^{2}$ Prior-year figures restated due to changes in revenue reserves and other reserves.
Provisions of €351m (333m) for basic claims from prior years were reversed in Q3; this figure corresponds to $5.0 \%(5.1 \%)$ of net insurance revenue. Munich Re continually seeks to recognise the amount of provisions for newly emerging claims at the very top end of the estimation range so that gains from the reversal of a portion of these provisions can be generated at a later stage.
Munich Re generated a result of €164m (173m) in its ERGO business segment in Q3 and $€ 699 \mathrm{~m}(643 \mathrm{~m})$ in Q1-3. Insurance revenue from insurance contracts issued increased to $€ 5,271 \mathrm{~m}(5,004 \mathrm{~m})$, and rose markedly to $€ 15,553 \mathrm{~m}(14,920 \mathrm{~m})$ in Q1-3.
In Q3, the result of the ERGO Life and Health Germany segment expanded to €73m (52m). The expected release of the contractual service margin from the longestablished life and health insurance business contributed significantly to this. Furthermore, the short-term health and travel insurance business performed largely in line with expectations and made a positive contribution to the result.
The result generated by the ERGO Property-casualty Germany segment increased appreciably to $€ 68 \mathrm{~m}(31 \mathrm{~m})$ in Q3, driven by a higher total technical result resulting from overall good operating performance. At the same time, the result was also influenced by the persistently high claims inflation in the German motor insurance business and the major claims trend, which was slightly above expectations. The segment result was also bolstered by a good investment result.
The ERGO International segment generated a Q3 result of €23m (90m), due primarily to losses in Poland and Austria connected with the catastrophic flooding caused by Storm Boris in September. The Spanish insurance business was also weighed down by an unfavourable claims trend. Overall, the profitability of the international life and health insurance business was in line with expectations, thanks in part to the positive performance of Belgian health insurance business.
In Q3, the segment's total technical result amounted to €532m (595m) and the operating result to €238m (281m). The Property-casualty Germany segment's combined ratio decreased from $88.2 \%$ in the prior-year quarter to $86.0 \%$ in Q3, owing particularly to losses resulting from natural catastrophes. In Q1-3, the segment's combined ratio was $86.2 \%(85.8 \%)$. For Q3, the International segment's combined ratio came to $96.1 \%(87.9 \%)$ due to higher claims expenditure from the flood catastrophe and from Spanish health insurance business. In Q1-3, the segment's combined ratio was $92.4 \%(90.3 \%)$.
Munich Re's Q3 investment result rose to €2,091m (760m). Regular income from investments increased to $€ 2,026 \mathrm{~m}(1,797 \mathrm{~m})$, which was due primarily to ongoing reinvestments with high interest rates. The balance from write-ups and write-downs was -€138m (-26m), with the balance from gains and losses on the disposal of investments running to -€115m (-196m). The change in fair value amounted to €467m $(-579 \mathrm{~m})$. This improved result owed chiefly to gains from equity portfolios borne by the positive performance of the equity markets. Furthermore, declining interest rates in Q3 translated to higher market values in the portfolio of fixed-interest securities. Losses from the disposal of fixed-interest bonds were once again recognised. This practice was continued purposefully in order to benefit more quickly from reinvesting in bonds with higher fixed interest rates in the persistently high interest rate environment.
Overall, the Q3 investment result represented a return of $3.6 \%$ on the average market value of the portfolio. The running yield was $3.5 \%$ and the yield on reinvestment was $4.3 \%$. As at 30 September 2024, the equity-backing ratio - including equity-linked derivatives - came to 3.0\% (31 December 2023: 3.7\%). The carrying amount of the investment portfolio as at 30 September 2024 was €225,668m (218,462m).
Munich Re is well positioned to outperform its annual target of $€ 5.0$ bn. In other words, Munich Re is aiming for a net result of more than $€ 5.0$ bn for the 2024 financial year.
In the reinsurance field of business, Munich Re expects to generate a net profit of more than $€ 4.2$ bn (previously: circa $€ 4.2$ bn) and insurance revenue of approximately $€ 40$ bn (previously: about €39bn) in financial year 2024. The life and health reinsurance business is forecast to generate a total technical result of approximately $€ 2.0$ bn (previously: around $€ 1.45$ bn). Munich Re anticipates that the net combined ratio in the property-casualty reinsurance business will amount to approximately $83 \%$ (previously: roughly $82 \%$ ). The ERGO business segment is now expected to generate insurance revenue of about €21bn (previously: approximately €20bn). We therefore now predict that Munich Re Group's insurance revenue will total around $€ 61$ bn (previously: around $€ 59$ bn). Munich Re expects the net combined ratio in the ERGO Property-casualty Germany segment to amount to some 89\% (previously: about 87\%). In addition, Munich Re anticipates that the net combined ratio in the ERGO International segment will be around $92 \%$ (previously: about $90 \%$ ). A profit in the order of $€ 0.8$ bn continues to be foreseen for the ERGO business segment. Munich Re's other forecasts for 2024 remain valid and have not changed since the 2024 Half-Year Financial Report was published in August.
As usual, all projections and targets are subject to increased uncertainties stemming from geopolitical and macroeconomic developments, to major losses remaining within normal bounds, and to the income statement not being impacted by severe fluctuations
in the currency or capital markets, significant changes in the tax environment, or other one-off effects.
Münchener Rückversicherungs-Gesellschaft
Aktiengesellschaft in München
Group Media Relations
Königinstrasse 107, 80802 Munich, Germany
www.munichre.com
LinkedIn: https://de.linkedin.com/company/munich-re
For Media inquiries please contact
| Group Media Relations Stefan Straub | Financial Communications Axel Rakette | Group Media Relations Irmgard Joas |
|---|---|---|
| Tel.: +49 893891 9896 | Tel.: +49 8938913141 | Tel.: +49 8938916188 |
| Mobile: +49 15164933048 | Mobile: +49 15120462132 | Mobile: +49 15152817024 |
| [email protected] | [email protected] | [email protected] |
| Media Relations Asia-Pacific | Media Relations North America | Media Relations London Market |
| Faith Thoms | Ashleigh Lockhart | Lillian Ng |
| Tel.: +65 63180762 | Tel.: +1 609 275-2110 | Tel.: +44 207 8863952 |
| Mobile: +65 83390125 | Mobile: +1 980 395-2979 | Mobile: +44 7809 495299 |
| [email protected] | [email protected] | [email protected] |
Munich Re is one of the world's leading providers of reinsurance, primary insurance and insurance-related risk solutions. The group consists of the reinsurance and ERGO business segments, as well as the asset management company MEAG. Munich Re is globally active and operates in all lines of the insurance business. Since it was founded in 1880, Munich Re has been known for its unrivalled risk-related expertise and its sound financial position. Munich Re leverages its strengths to promote its clients' business interests and technological progress. Moreover, Munich Re develops covers for new risks such as rocket launches, renewable energies, cyber risks and artificial intelligence. In the 2023 financial year, Munich Re generated insurance revenue of $€ 57.9$ bn and a net result of $€ 4.6$ bn. The Munich Re Group employed about 43,000 people worldwide as at 31 December 2023.
This media release contains forward-looking statements that are based on current assumptions and forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. The Company assumes no liability to update these forward-looking statements or to make them conform to future events or developments.
Key figures


ERGO
| Q1-3 2024 | Q1-3 2023 | Change | Q3 2024 | Q3 2023 | Change | |
|---|---|---|---|---|---|---|
| $\%$ | $\%$ | |||||
| Insurance revenue from insurance contracts issued | €m | 15.553 | 14.920 | 4,2 | 5.271 | 5.004 |
| Combined ratio Property-casualty Germany | \% | 86,2 | 85,8 | 86,0 | 88,2 | |
| Combined ratio International | \% | 92,4 | 90,3 | 96,1 | 87,9 | |
| Investment result | €m | 3.107 | 1.372 | 126,5 | 1.287 | 272 |
| Net result | €m | 699 | 643 | 8,7 | 164 | 173 |
| Thereof: Life and Health Germany | €m | 228 | 165 | 37,7 | 73 | 52 |
| Thereof: Property-casualty Germany | €m | 237 | 260 | $-8,6$ | 68 | 31 |
| Thereof: International | €m | 234 | 218 | 7,4 | 23 | 90 |
| Return on equity (RoE) ${ }^{1}$ | \% | 18,3 | 15,8 | 13,1 | 13,5 |
[^0]
[^0]: ${ }^{1}$ Previous year's figures adjusted due to changes in "Retained earnings" and "Other reserves".
| As at 30.09.2024 | From Annual Report 2023 | ||
|---|---|---|---|
| Insurance revenue from insurance contracts issued | €bn | 61 | 59 |
| Total technical result - Life and health reinsurance | €bn | 2,0 | 1.45 |
| Combined ratio - Property-casualty reinsurance | \% | 83 | 82 |
| Combined ratio - ERGO Property-casualty Germany | \% | 89 | 87 |
| Combined ratio - ERGO International | \% | 92 | 90 |
| Return on investment | \% | over 2.8 | over 2.8 |
| Net result | €bn | over 5.0 | 5.0 |
| Economic Earnings | €bn | over 5.0 | over 5.0 |
| Investment result | ||||||
|---|---|---|---|---|---|---|
| Q1-3 2024 | Rol ${ }^{1}$ | Q1-3 2023 | Rol ${ }^{1}$ | Q3 2024 | Q3 2023 | |
| €m | \% | €m | \% | €m | €m | |
| Regular income | 6.114 | 3,6 | 5.162 | 3,2 | 2.026 | 1.797 |
| Write-ups/write-downs | $-248$ | $-0,1$ | $-64$ | 0,0 | $-138$ | $-26$ |
| Change in expected credit losses | 10 | 0,0 | $-95$ | $-0,1$ | 32 | $-69$ |
| Gains/losses on disposal | $-316$ | $-0,2$ | $-425$ | $-0,3$ | $-115$ | $-196$ |
| Fair value changes | 660 | 0,4 | $-1.114$ | $-0,7$ | 467 | $-579$ |
| Other income/expenses | $-496$ | $-0,3$ | $-494$ | $-0,3$ | $-182$ | $-168$ |
| Total | 5.724 | 3,4 | 2.969 | 1,8 | 2.091 | 760 |
[^0]
[^0]: ${ }^{1}$ Annualised return in \% p.a. on the average fair value of the investment portfolio at the quarterly reporting dates.
| 30.9.2024 | 31.12.2023 | Change | ||||
|---|---|---|---|---|---|---|
| €m | €m | €m | €m | €m | \% | |
| A. Intangible assets | ||||||
| I. Goodwill | 3.304 | 3.184 | 120 | 3,8 | ||
| II. Other intangible assets | 805 | 900 | $-95$ | $-10,6$ | ||
| 4.108 | 4.084 | 25 | 0,6 | |||
| B. Reinsurance contracts held that are assets | 4.072 | 4.014 | 58 | 1,4 | ||
| C. Insurance contracts issued that are assets | 7.383 | 7.193 | 191 | 2,7 | ||
| D. Investments | ||||||
| I. Non-financial investments | ||||||
| 1. Investment property | 9.817 | 9.384 | 433 | 4,6 | ||
| 2. Property, plant and equipment | 458 | 511 | $-53$ | $-10,3$ | ||
| 3. Intangible assets | 77 | 128 | $-50$ | $-39,4$ | ||
| 4. Biological assets | 1.082 | 828 | 254 | 30,6 | ||
| 5. Inventories | 0 | 0 | 0 | - | ||
| 6. Investments in affiliated companies, associates and joint ventures | ||||||
| 5.077 | 6.895 | $-1.818$ | $-26,4$ | |||
| Thereof: Associates and joint ventures accounted for using the equity | ||||||
| 4.556 | 6.409 | $-1.853$ | $-28,9$ | |||
| 16.512 | 17.747 | $-1.235$ | $-7,0$ | |||
| II. Financial investments | 209.156 | 200.715 | 8.441 | 4,2 | ||
| 225.668 | 218.462 | 7.206 | 3,3 | |||
| E. Investments for unit-linked life insurance | 9.029 | 8.280 | 749 | 9,0 | ||
| F. Insurance-related financial instruments | 8.539 | 9.872 | $-1.333$ | $-13,5$ | ||
| G. Receivables | ||||||
| I. Current tax receivables | 857 | 1.920 | $-1.063$ | $-55,4$ | ||
| II. Financial receivables | 4.113 | 3.841 | 272 | 7,1 | ||
| III. Other receivables | 1.608 | 1.382 | 226 | 16,3 | ||
| 6.578 | 7.143 | $-565$ | $-7,9$ | |||
| H. Cash and cash equivalents | 6.524 | 5.595 | 929 | 16,6 | ||
| I. Deferred tax assets | 2.440 | 2.743 | $-302$ | $-11,0$ | ||
| J. Other assets | 5.482 | 5.962 | $-480$ | $-8,1$ | ||
| K. Non-current assets held for sale | 183 | 446 | $-263$ | $-59,0$ | ||
| Total assets | 280.007 | 273.793 | 6.214 | 2,3 |
Equity and liabilities
| 30.9.2024 | 31.12.2023 | Change | |||
|---|---|---|---|---|---|
| €m | €m | €m | €m | \% | |
| A. Equity | |||||
| I. Issued capital and capital reserve | 7.424 | 7.424 | 0,0 | ||
| II. Retained earnings | 19.673 | 18.216 | 1.457 | ||
| III. Other reserves | $-487$ | $-597$ | 110 | ||
| IV Net result attributable to Munich Reinsurance Company equity holders | 4.694 | 4.606 | 87 | ||
| V. Non-controlling interests | 120 | 122 | $-2$ | ||
| 31.425 | 29.772 | 1.652 | |||
| B. Subordinated liabilities | 6.211 | 4.713 | 1.499 | ||
| C. Reinsurance contracts held that are liabilities | 550 | 436 | 113 | ||
| D. Insurance contracts issued that are liabilities | |||||
| I. Liability for remaining coverage | 133.334 | 132.979 | 355 | ||
| II. Liability for incurred claims | 86.480 | 81.167 | 5.313 | ||
| III. Other technical liabilities | 7 | 7 | 5,0 | ||
| 219.821 | 214.153 | 5.669 | |||
| E. Other provisions | 2.664 | 2.766 | $-101$ | ||
| F. Liabilities | |||||
| I. Derivatives | 1.072 | 1.379 | $-307$ | ||
| II. Non derivative financial liabilities | 3.494 | 4.161 | $-666$ | ||
| III. Current tax liabilities | 2.235 | 2.657 | $-422$ | ||
| IV Other liabilities | 10.669 | 11.242 | $-573$ | ||
| 17.470 | 19.438 | $-1.969$ | |||
| G. Deferred tax liabilities | 1.850 | 2.241 | $-391$ | ||
| H. Liabilities related to non-current assets held for sale | 16 | 274 | $-258$ | ||
| Total equity and liabilities | 280.007 | 273.793 | 6.214 |
| Q1–3 2024 | Q1–3 2023 | Change | |||
|---|---|---|---|---|---|
| €m | €m | €m | €m | % | |
| 1. Insurance revenue from insurance contracts issued | 45,510 | 42.908 | 2.602 6,1 | ||
| 2. Insurance service expenses from insurance contracts issued | -38.235 | -36.549 | -1.686 | ||
| Claims expenses | -32.151 | -30.442 | -1.709 | ||
| Changes from underlying items | 400 | -55 | 455 | ||
| Administration and acquisition costs | -6.484 | -6.052 | -432 | ||
| Other insurance service expenses | 0 | 0 | 0 | ||
| 3. Insurance service result from insurance contracts issued (1+2) | 7.275 | 6.359 | 916 | ||
| 4. Insurance revenue ceded from reinsurance contracts held | -1.355 | -1.072 | -283 | ||
| 5. Income from reinsurance contracts held | 552 | 503 | 49 | ||
| 6. Insurance service result from reinsurance contracts held (4+5) | -803 | -569 | -234 | ||
| 7. Insurance service result (3+6) | 6.472 | 5.790 | 682 | ||
| 8. Result from insurance-related financial instruments | 484 | 399 | 85 | ||
| 9. Total technical result (7+8) | 6.956 | 6.189 | 767 | ||
| 10. Investment result | 5.724 | 2.969 | 2.755 | ||
| 11. Currency result | -277 | 208 | -485 | ||
| 12. Investment result for unit-linked life insurance | 766 | 411 | 355 | ||
| 13. Insurance finance income or expenses from insurance contracts issued | -5.410 | -3.216 | -2.194 | ||
| 14. Insurance finance income or expenses from reinsurance contracts held | 80 | 68 | 12 | ||
| 15. Insurance finance income or expenses (13+14) | -5.330 | -3.148 | -2.182 | ||
| 16. Net financial result (10+11+12+15) | 883 | 440 | 443 | ||
| 17. Other operating income | 954 | 854 | 99 | ||
| 18. Other operating expenses | -2.460 | -2.367 | -93 | ||
| 19. Operating result (9+16+17+18) | 6.333 | 5.117 | 1.216 | ||
| 20. Net finance costs | -148 | -126 | -22 | ||
| 21. Taxes on income | -1.492 | -1.397 | -95 | ||
| 22. Net result (19+20+21) | 4.692 | 3.593 | 1.099 | ||
| Thereof: | |||||
| Attributable to Munich Reinsurance Company equity holders | 4.694 | 3.595 | 1.098 | ||
| Attributable to non-controlling interests | -1 | -2 | 1 | ||
| Earnings per share | 35.20 | 26.36 | 8.84 |
| Q3 2024 | Q3 2023 | Change | |||
|---|---|---|---|---|---|
| €m | €m | €m | €m | % | |
| 1. Insurance revenue from insurance contracts issued | 15.496 | 14.460 | 1.036 | ||
| 2. Insurance service expenses from insurance contracts issued | -13.478 | -12.158 | -1.320 | ||
| Claims expenses | -11.531 | -10.189 | -1.342 | ||
| Changes from underlying items | 197 | 100 | 97,3 | ||
| Administration and acquisition costs | -2.143 | -2.068 | -76 | ||
| Other insurance service expenses | 0 | 0 | 0 | ||
| 3. Insurance service result from insurance contracts issued (1+2) | 2.018 | 2.302 | -285 | ||
| 4. Insurance revenue ceded from reinsurance contracts held | -559 | -408 | -152 | ||
| 5. Income from reinsurance contracts held | 96 | 119 | -24 | ||
| 6. Insurance service result from reinsurance contracts held (4+5) | -464 | -289 | -175 | ||
| 7. Insurance service result (3+6) | 1.554 | 2.014 | -460 | ||
| 8. Result from insurance-related financial instruments | 97 | 207 | -110 | ||
| 9. Total technical result (7+8) | 1.651 | 2.221 | -570 | ||
| 10. Investment result | 2.091 | 760 | 1.330 | ||
| 11. Currency result | -383 | 309 | -692 | ||
| 12. Investment result for unit-linked life insurance | 112 | -79 | 190 | ||
| 13. Insurance finance income or expenses from insurance contracts issued | -1.826 | -940 | -885 | ||
| 14. Insurance finance income or expenses from reinsurance contracts held | 27 | 25 | 2 | ||
| 15. Insurance finance income or expenses (13+14) | -1.799 | -915 | -884 | ||
| 16. Net financial result (10+11+12+15) | 21 | 75 | -55 | ||
| 17. Other operating income | 286 | 272 | 14 | ||
| 18. Other operating expenses | -763 | -792 | 29 | ||
| 19. Operating result (9+16+17+18) | 1.194 | 1.776 | -582 | ||
| 20. Net finance costs | -57 | -42 | -14 | ||
| 21. Taxes on income | -207 | -565 | 358 | ||
| 22. Net result (19+20+21) | 930 | 1.169 | -239 | ||
| Thereof: | |||||
| Attributable to Munich Reinsurance Company equity holders | 930 | 1.168 | -238 | ||
| Attributable to non-controlling interests | 0 | 1 | -1 | ||
| Earnings per share | 7.02 | 8.61 | -1.59 | ||
| -18.4 |
| Segment assets | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Segment assets | Reinsurance | ERGO Property-casualty |
Total | ||||||||
| Life and health | Property-casualty | ||||||||||
| 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | |
| Km | 280 | 292 | 2.098 | 2.129 | 59 | 62 | 1.284 | 1.388 | 388 | 212 | 4.108 |
| A. Intangible assets | 732 | 667 | 2.437 | 2.518 | 19 | 16 | 382 | 381 | 501 | 431 | 4.072 |
| B. Reinsurance contracts held that are assets | 6.558 | 6.473 | 204 | 116 | 277 | 287 | 265 | 264 | 78 | 53 | 7.383 |
| C. Insurance contracts issued that are assets | 19.953 | 20.882 | 75.959 | 69.505 | 104.567 | 103.719 | 8.617 | 8.133 | 16.573 | 16.224 | 225.668 |
| D. Investments | 0 | 0 | 0 | 0 | 6.291 | 5.778 | 0 | 0 | 2.738 | 2.502 | 9.029 |
| E. Investments for unit-linked life insurance | 7.290 | 8.598 | 827 | 862 | 422 | 412 | 0 | 0 | 0 | 0 | 8.539 |
| F. Insurance-related financial instruments | 9 | 0 | 135 | 22 | 39 | 137 | 0 | 5 | 0 | 282 | 183 |
| G. Non-current assets held for sale | 3.672 | 4.340 | 9.720 | 9.592 | 4.925 | 4.843 | 1.385 | 1.360 | 1.323 | 1.309 | 21.025 |
| Total segment assets | 38.494 | 41.251 | 91.381 | 84.743 | 116.597 | 115.254 | 11.934 | 11.532 | 21.601 | 21.013 | 280.007 |
| Life and health | Property-casualty | Life and Health Germany | |||||||||
| 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | |
| A. Subordinated liabilities | 510 | 483 | 5.689 | 4.217 | 0 | 0 | 0 | 0 | 13 | 13 | 6.211 |
| B. Reinsurance contracts held that are liabilities | 176 | 112 | 131 | 148 | 4 | 2 | 105 | 96 | 133 | 78 | 550 |
| C. Insurance contracts issued that are liabilities | 16.650 | 17.383 | 64.721 | 61.705 | 115.315 | 113.095 | 7.102 | 6.592 | 16.033 | 15.378 | 219.821 |
| I. Liability for remaining coverage | 10.562 | 10.659 | $-4.087$ | $-1.799$ | 113.489 | 111.195 | 628 | 609 | 12.742 | 12.315 | 133.334 |
| III. Liability for incurred claims | 6.088 | 6.724 | 68.808 | 63.504 | 1.826 | 1.900 | 6.475 | 5.983 | 3.284 | 3.056 | 86.480 |
| II. Other technical Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 7 | 7 |
| D. Other provisions | 136 | 163 | 539 | 638 | 823 | 845 | 800 | 786 | 366 | 333 | 2.664 |
| E. Liabilities related to non-current assets held for sale | 1 | 0 | 15 | 1 | 0 | 0 | 0 | 0 | 0 | 273 | 16 |
| F. Other segment liabilities | 5.151 | 6.017 | 7.845 | 8.767 | 1.056 | 1.800 | 2.965 | 2.812 | 2.302 | 2.284 | 19.320 |
| Total segment liabilities | 22.625 | 24.159 | 78.939 | 75.476 | 117.198 | 115.742 | 10.973 | 10.287 | 18.847 | 18.358 | 248.582 |
| Equity | 31.425 | ||||||||||
| Total equity and liabilities | 280.007 | 273.793 |
| Risk adjustment for non-financial risk (total) ${ }^{1}$ | 3.589 | 3.480 | 383 | 398 | 639 | 539 | 85 | 82 | 156 | 188 | 4.852 | 4.687 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Contractual service margin (total) ${ }^{1}$ | 13.511 | 12.275 | 239 | 88 | 9.789 | 9.568 | 384 | 385 | 2.879 | 2.831 | 26.802 | 25.146 |
| Loss component by segment (total) | 228 | 222 | 502 | 574 | 20 | 19 | 110 | 192 | 258 | 279 | 1.119 | 1.286 |
[^0]
[^0]: ${ }^{1}$ Risk adjustment for non-financial risk and contractual service margin include ceded parts.
| Reinsurance | Total | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life and health | Property-casualty | Life and Health | |||||||||||||
| Germany | Germany | Germany | International | ||||||||||||
| Km | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | |||
| 1. Insurance revenue from insurance contracts issued | 8.924 | 7.950 | 21.033 | 20.038 | 7.520 | 7.404 | 3.529 | 3.346 | 4.504 | 4.170 | 45.510 | 42.908 | |||
| 2. Insurance service expenses from insurance contracts issued | $-7.727$ | $-7.201$ | $-16.732$ | $-16.326$ | $-6.760$ | $-6.570$ | $-3.035$ | $-2.823$ | $-3.981$ | $-3.629$ | $-38.235$ | $-36.549$ | |||
| Claims expenses | $-7.430$ | $-6.880$ | $-13.612$ | $-13.505$ | $-6.177$ | $-5.583$ | $-2.126$ | $-1.987$ | $-2.805$ | $-2.486$ | $-32.151$ | $-30.442$ | |||
| Changes from underlying items | 0 | 0 | 0 | 0 | 411 | $-48$ | $-1$ | $-1$ | $-10$ | $-6$ | 400 | $-55$ | |||
| Admin and acquisition cost | $-297$ | $-321$ | $-3.119$ | $-2.821$ | $-994$ | $-940$ | $-907$ | $-834$ | $-1.166$ | $-1.137$ | $-6.484$ | $-6.052$ | |||
| Other insurance service expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| 3. Insurance service result from insurance contracts issued (1+2) | 1.196 | 749 | 4.301 | 3.712 | 760 | 833 | 494 | 523 | 524 | 541 | 7.275 | 6.359 | |||
| 4. Insurance revenue ceded from reinsurance contracts held | $-198$ | $-105$ | $-860$ | $-724$ | $-11$ | $-6$ | $-81$ | $-55$ | $-205$ | $-182$ | $-1.355$ | $-1.072$ | |||
| 5. Income from reinsurance contracts held | 173 | 91 | 193 | 298 | 8 | 3 | 61 | $-2$ | 118 | 113 | 552 | 503 | |||
| 6. Insurance service result from reinsurance contracts held (4+5) | $-26$ | $-15$ | $-667$ | $-425$ | $-3$ | $-3$ | $-20$ | $-57$ | $-87$ | $-69$ | $-803$ | $-569$ | |||
| 7. Insurance service result (3+6) | 1.170 | 735 | 3.634 | 3.286 | 757 | 831 | 474 | 466 | 437 | 472 | 6.472 | 5.790 | |||
| 8. Result from insurance-related financial instruments | 461 | 350 | 45 | 63 | $-21$ | $-12$ | 0 | 0 | $-1$ | $-2$ | 484 | 399 | |||
| 9. Total technical result (7+8) | 1.632 | 1.084 | 3.679 | 3.350 | 736 | 819 | 474 | 466 | 436 | 470 | 6.956 | 6.189 | |||
| 10. Investment result | 552 | 424 | 2.065 | 1.173 | 2.518 | 994 | 208 | 127 | 380 | 251 | 5.724 | 2.969 | |||
| 11. Currency result | $-84$ | $-7$ | $-29$ | 210 | $-121$ | 18 | $-24$ | $-12$ | $-19$ | $-2$ | $-277$ | 208 | |||
| 12. Investment result for unit-linked life insurance | 0 | 0 | 0 | 0 | 537 | 306 | 0 | 0 | 229 | 105 | 766 | 411 | |||
| 13. Insurance finance income or expenses from insurance contracts issued | $-120$ | $-100$ | $-1.686$ | $-1.306$ | $-3.009$ | $-1.425$ | $-86$ | $-38$ | $-509$ | $-348$ | $-5.410$ | $-3.216$ | |||
| 14. Insurance finance income or expenses from reinsurance contracts held | 1 | 1 | 68 | 61 | 0 | $-1$ | 2 | 1 | 9 | 6 | 80 | 68 | |||
| 15. Insurance finance income or expenses (13+14) | $-119$ | $-99$ | $-1.618$ | $-1.245$ | $-3.009$ | $-1.426$ | $-84$ | $-37$ | $-500$ | $-342$ | $-5.330$ | $-3.148$ | |||
| 16. Net financial result (10+11+12+15) | 350 | 319 | 418 | 138 | $-75$ | $-108$ | 100 | 78 | 90 | 12 | 883 | 440 | |||
| 17. Other operating income | 236 | 203 | 414 | 360 | 103 | 99 | 78 | 72 | 123 | 120 | 954 | 854 | |||
| 18. Other operating expenses | $-343$ | $-306$ | $-990$ | $-965$ | $-525$ | $-560$ | $-257$ | $-230$ | $-345$ | $-306$ | $-2.460$ | $-2.367$ | |||
| 19. Operating result (9+16+17+18) | 1.874 | 1.301 | 3.521 | 2.883 | 239 | 250 | 395 | 386 | 304 | 297 | 6.333 | 5.117 | |||
| 20. Net finance costs | 16 | $-1$ | $-141$ | $-102$ | 62 | 37 | $-50$ | $-35$ | $-36$ | $-26$ | $-148$ | $-126$ | |||
| 21. Taxes on income | $-394$ | $-332$ | $-883$ | $-799$ | $-73$ | $-121$ | $-108$ | $-91$ | $-34$ | $-54$ | $-1.492$ | $-1.397$ | |||
| 22. Net result (19+20+21) | 1.496 | 968 | 2.497 | 1.982 | 228 | 165 | 237 | 260 | 234 | 218 | 4.692 | 3.593 | |||
| Tax ratio (in \%) | 20,8\% | 25,6\% | 26,1\% | 28,7\% | 24,4\% | 42,3\% | 31,3\% | 26,0\% | 12,6\% | 19,7\% | 24,1\% | 28,0\% | |||
| RoE (in \%) | 20,1\% | 16,6\% |
| Reinsurance | ERGO | Total | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Life and health | Property-casualty | Life and Health | Property-casualty | |||||||||
| Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | |
| 1. Insurance revenue from insurance contracts issued | 2.936 | 2.610 | 7.298 | 6.845 | 2.574 | 2.487 | 1.210 | 1.100 | 1.487 | 1.417 | 15.496 | 14.460 |
| 2. Insurance service expenses from insurance contracts issued | $-2.557$ | $-2.390$ | $-6.195$ | $-5.448$ | $-2.313$ | $-2.190$ | $-1.052$ | $-940$ | $-1.361$ | $-1.189$ | $-13.478$ | $-12.158$ |
| Claims expenses | $-2.471$ | $-2.280$ | $-5.133$ | $-4.462$ | $-2.188$ | $-1.957$ | $-762$ | $-678$ | $-980$ | $-813$ | $-11.531$ | $-10.189$ |
| Changes from underlying items | 0 | 0 | 0 | 0 | 213 | 91 | 0 | 0 | $-16$ | 9 | 197 | 100 |
| Admin and acquisition cost | $-97$ | $-111$ | $-1.062$ | $-986$ | $-340$ | $-324$ | $-289$ | $-262$ | $-365$ | $-385$ | $-2.143$ | $-2.068$ |
| Other insurance service expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3. Insurance service result from insurance contracts issued (1+2) | 379 | 220 | 1.093 | 1.397 | 261 | 297 | 158 | 160 | 126 | 228 | 2.018 | 2.302 |
| 4. Insurance revenue ceded from reinsurance contracts held | $-134$ | $-30$ | $-321$ | $-281$ | $-4$ | $-3$ | $-27$ | $-15$ | $-74$ | $-78$ | $-559$ | $-408$ |
| 5. Income from reinsurance contracts held | 121 | 32 | $-108$ | 63 | 3 | $-1$ | 34 | $-17$ | 45 | 42 | 96 | 119 |
| 6. Insurance service result from reinsurance contracts held (4+5) | $-13$ | 2 | $-429$ | $-218$ | $-1$ | $-4$ | 8 | $-32$ | $-29$ | $-36$ | $-464$ | $-289$ |
| 7. Insurance service result (3+6) | 366 | 222 | 664 | 1.179 | 260 | 293 | 166 | 128 | 97 | 192 | 1.554 | 2.014 |
| 8. Result from insurance-related financial instruments | 82 | 218 | 27 | 7 | 8 | $-17$ | 0 | 0 | 1 | 0 | 97 | 207 |
| 9. Total technical result (7+8) | 428 | 440 | 691 | 1.186 | 269 | 276 | 166 | 128 | 97 | 192 | 1.651 | 2.221 |
| 10. Investment result | 202 | 152 | 602 | 336 | 1.096 | 180 | 62 | 22 | 129 | 70 | 2.091 | 760 |
| 11. Currency result | $-93$ | $-31$ | $-101$ | 198 | $-175$ | 137 | $-13$ | 0 | $-2$ | 5 | $-383$ | 309 |
| 12. Investment result for unit-linked life insurance | 0 | 0 | 0 | 0 | 75 | $-19$ | 0 | 0 | 37 | $-60$ | 112 | $-79$ |
| 13. Insurance finance income or expenses from insurance contracts issued | $-34$ | $-39$ | $-559$ | $-531$ | $-1.050$ | $-337$ | $-36$ | $-21$ | $-147$ | $-12$ | $-1.926$ | $-940$ |
| 14. Insurance finance income or expenses from reinsurance contracts held | 0 | $-1$ | 22 | 24 | 0 | 0 | 1 | 1 | 3 | 2 | 27 | 25 |
| 15. Insurance finance income or expenses (13+14) | $-33$ | $-41$ | $-537$ | $-507$ | $-1.050$ | $-337$ | $-35$ | $-20$ | $-144$ | $-10$ | $-1.799$ | $-915$ |
| 16. Net financial result (10+11+12+15) | 76 | 80 | $-35$ | 27 | $-94$ | $-39$ | 14 | 1 | 20 | 5 | 21 | 75 |
| 17. Other operating income | 79 | 71 | 134 | 100 | 12 | 39 | 33 | 25 | 27 | 37 | 286 | 272 |
| 18. Other operating expenses | $-118$ | 95 | $-299$ | $-314$ | $-150$ | $-190$ | $-96$ | $-83$ | $-100$ | $-110$ | $-763$ | $-792$ |
| 19. Operating result (9+16+17+18) | 465 | 495 | 491 | 999 | 77 | 86 | 117 | 71 | 44 | 124 | 1.194 | 1.776 |
| 20. Net finance costs | 4 | 1 | $-53$ | $-35$ | 22 | 14 | $-17$ | $-13$ | $-12$ | $-10$ | $-57$ | $-42$ |
| 21. Taxes on income | $-78$ | $-145$ | $-62$ | $-320$ | $-26$ | $-48$ | $-32$ | $-28$ | $-9$ | $-24$ | $-207$ | $-565$ |
| 22. Net result (19+20+21) | 391 | 351 | 375 | 644 | 73 | 52 | 68 | 31 | 23 | 90 | 930 | 1.168 |
| Tax ratio (in \%) | 16,7\% | 29,3\% | 14,3\% | 33,2\% | 26,1\% | 47,7\% | 32,0\% | 47,7\% | 27,9\% | 21,0\% | 18,2\% | 32,6\% |
| RoE (in \%) | 11,7\% | 16,0\% |
Notes on determining the combined ratio
| Reinsurance | ERGO | |||||
|---|---|---|---|---|---|---|
| Property-casualty | Property-casualty Germany | International ${ }^{1}$ | ||||
| €m | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 |
| Insurance revenue from insurance contracts issued | 21.033 | 20.038 | 3.529 | 3.346 | 3.620 | 3.268 |
| Insurance revenue ceded from reinsurance contracts held | $-860$ | $-724$ | $-81$ | $-55$ | $-196$ | $-160$ |
| Insurance revenue (net) | 20.173 | 19.314 | 3.448 | 3.291 | 3.424 | 3.108 |
| Insurance service expenses from insurance contracts issued | $-16.732$ | $-16.326$ | $-3.035$ | $-2.823$ | $-3.277$ | $-2.914$ |
| Income from reinsurance contracts held | 193 | 298 | 61 | $-2$ | 113 | 106 |
| Insurance service expenses (net) | $-16.539$ | $-16.028$ | $-2.974$ | $-2.825$ | $-3.164$ | $-2.808$ |
| Combined ratio | \% | 82,0 | 83,0 | 86,2 | 85,8 | 92,4 |
[^0]
[^0]: ${ }^{1}$ Property-casualty business, travel insurance business and short-term health insurance business (excluding health insurance conducted like life insurance).
| Reinsurance | ERGO | |||||
|---|---|---|---|---|---|---|
| Life \& Health | Life \& Health Germany | Life \& Health International | ||||
| €m | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 | Q1-3 2024 | Q1-3 2023 |
| Release of CSM | 770 | 638 | 601 | 675 | 154 | 131 |
| Release of risk adjustment (non-PAA) | 227 | 186 | 25 | 26 | 8 | 8 |
| Experience adjustments not adjusted against CSM (non-PAA) | 233 | $-61$ | 30 | $-5$ | 61 | 64 |
| Onerous contracts and changes not affecting CSM (non-PAA) | $-60$ | $-30$ | $-17$ | $-23$ | $-13$ | $-1$ |
| Insurance service result from PAA business | 0 | 2 | 118 | 157 | 6 | 44 |
| Insurance service result | 1.170 | 735 | 757 | 831 | 217 | 246 |
| Result from insurance-related financial instruments | 461 | 350 | $-21$ | $-12$ | 0 | 0 |
| Total technical result | 1.632 | 1.084 | 736 | 819 | 217 | 246 |
| Reinsurance | ERGO | |||||
|---|---|---|---|---|---|---|
| Life \& Health | Life \& Health Germany | Life \& Health International | ||||
| €m | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 | Q3 2024 | Q3 2023 |
| Release of CSM | 247 | 215 | 195 | 226 | 36 | 38 |
| Release of risk adjustment (non-PAA) | 75 | 62 | 8 | 9 | 3 | 3 |
| Experience adjustments not adjusted against CSM (non-PAA) | 41 | $-58$ | 21 | $-1$ | 33 | 40 |
| Onerous contracts and changes not affecting CSM (non-PAA) | 2 | 2 | $-5$ | $-8$ | $-18$ | 1 |
| Insurance service result from PAA business | 0 | 1 | 40 | 67 | 10 | 23 |
| Insurance service result | 366 | 222 | 260 | 293 | 63 | 105 |
| Result from insurance-related financial instruments | 62 | 218 | 9 | $-17$ | 0 | 0 |
| Total technical result | 428 | 440 | 269 | 276 | 63 | 105 |
| Reinsurance | ERGO | |||||
|---|---|---|---|---|---|---|
| Life \& Health | Life \& Health | Life \& Health | ||||
| €m | CSM | RA | Germany | International | ||
| CSM | RA | CSM | RA | |||
| 31.12.2023 | 12.275 | 3.480 | 9.568 | 539 | 2.627 | 156 |
| New contracts added | 1.771 | 331 | 128 | 6 | 210 | 6 |
| Accretion of interest | 259 | 72 | 0 | 0 | 22 | 2 |
| Operating changes | 57 | -133 | 695 | 119 | -68 | -40 |
| Change in financial effects | -80 | 67 | 0 | 0 | 2 | 4 |
| Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Release (through P\&L) | -770 | -227 | -601 | -25 | -154 | -8 |
| $\mathbf{3 0 . 9 . 2 0 2 4}$ | $\mathbf{1 3 . 5 1 1}$ | $\mathbf{3 . 5 8 9}$ | $\mathbf{9 . 7 8 9}$ | $\mathbf{6 3 9}$ | $\mathbf{2 . 6 3 8}$ | $\mathbf{1 2 0}$ |
${ }^{1}$ Net of reinsurance.
Notes on determining the annualised return on equity (RoE)
| Reinsurance | ERGO | Total | ||||
|---|---|---|---|---|---|---|
| €m | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 | 30.9.2024 | 31.12.2023 |
| Segment assets | 129.875 | 125.994 | 150.132 | 147.799 | 280.007 | 273.793 |
| Segment liabilities | 101.564 | 99.634 | 147.019 | 144.387 | 248.582 | 244.021 |
| Adjustments used in the calculation of equity measurement of insurance contracts, currency between reinsurance and ERGO | 465 | 189 | $-952$ | $-785$ | $-487$ | $-597$ |
| 976 | 940 | $-976$ | $-940$ | 0 | 0 | |
| Adjusted equity | 26.870 | 25.231 | 5.041 | 5.138 | 31.911 | 30.369 |
| Q1-3 2024 | Q1-3 2024 | Q1-3 2024 | ||||
| Average adjusted equity | 26.051 | 5.089 | 31.140 | |||
| Net result | 3.993 | 699 | 4.692 | |||
| Return on equity (RoE) | \% | 20,4 | 18,3 | 20,1 |
Notes on determining the annualised return on equity (RoE)
| Reinsurance | ERGO | Total | ||||
|---|---|---|---|---|---|---|
| €m | 30.9.2023 | 31.12.2022 | 30.9.2023 | 31.12.2022 | 30.9.2023 | 31.12.2022 |
| Segment assets | 123.080 | 127.087 | 141.590 | 142.304 | 264.670 | 269.391 |
| Segment liabilities | 98.970 | 102.950 | 138.053 | 139.196 | 237.023 | 242.146 |
| Adjustments used in the calculation of equity measurement of insurance contracts, currency between reinsurance and ERGO | $-683$ | 417 | $-1.260$ | $-1.439$ | $-1.943$ | $-1.022$ |
| 509 | 976 | $-509$ | $-976$ | 0 | 0 | |
| Adjusted equity | 24.284 | 22.743 | 5.306 | 5.524 | 29.590 | 28.267 |
| Q1-3 2023 | Q1-3 2023 | Q1-3 2023 | ||||
| Average adjusted equity | 23.514 | 5.415 | 28.929 | |||
| Net result | 2.950 | 643 | 3.593 | |||
| Return on equity (RoE) | \% | 16,7 | 15,8 | 16,6 |
[^0]
[^0]: ${ }^{1}$ Adjusted due to changes in Retained earnings and Other reserves.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.